| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.052 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |